Pacira Pharmaceuticals Inc (PCRX)

Operating return on assets (Operating ROA)

		Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Operating income	US$ in thousands	87,675	60,024	89,924	46,350	10,480
Total assets	US$ in thousands	1,574,390	1,681,200	2,075,350	1,274,510	831,065
Operating ROA		5.57%	3.57%	4.33%	3.64%	1.26%

December 31, 2023 calculation

Operating ROA = Operating income ÷ Total assets
= $87,675K ÷ $1,574,390K
= 5.57%

Pacira BioSciences Inc's operating return on assets (ROA) has demonstrated fluctuations over the five-year period from 2019 to 2023. The company's operating ROA ranged from 4.04% in 2020 to 6.40% in 2021, indicating variability in the efficiency with which the company generates operating profits relative to its total assets.

In 2021, Pacira BioSciences achieved its highest operating ROA of 6.40%, suggesting improved operational efficiency and profitability compared to the other years. However, in 2020, the company experienced a lower operating ROA of 4.04%, indicating a potential decline in operational performance during that period.

Overall, despite fluctuations year over year, Pacira BioSciences Inc maintained an average operating ROA of approximately 4.90% over the five-year period, showcasing a moderate level of efficiency in utilizing its assets to generate operating income. It is essential for investors and stakeholders to monitor these trends to assess the company's operational performance and financial health accurately.